...
首页> 外文期刊>European review for medical and pharmacological sciences. >Protective effect of resveratrol on kidney in rats with diabetic nephropathy and its effect on endoplasmic reticulum stress
【24h】

Protective effect of resveratrol on kidney in rats with diabetic nephropathy and its effect on endoplasmic reticulum stress

机译:白藜芦醇对糖尿病肾病大鼠肾脏的保护作用及其对内质网应激的影响

获取原文
           

摘要

OBJECTIVE: Diabetic nephropathy (DN) can cause chronic renal insufficiency and significantly reduce the life quality of patients with diabetes mellitus, and may eventually lead to death. The study investigated the expression of endoplasmic reticulum stress-related factors, which have important roles in the progress of DN and to explore effects of resveratrol on DN and the possible mechanism. MATERIALS AND METHODS: Specific pathogen free (SPF) grade healthy male Sprague Dawley (SD) rats were divided into different groups for different treatments. The diabetic rat model was established by intraperitoneal injection of low-dose streptozotocin (STZ) (40 mg/kg). The normal rats and diabetes model rats were divided into four groups including normal control group (N), normal control + resveratrol (N+R), model group (M), and model + resveratrol group (M+R) for different treatments. The changes of renal histology were observed by immunohistochemistry. Glucose oxidase/peroxidase method was used to measure FPG, UP 24 h content was measured by bicinchoninic acid (BCA) assay, BUN, Scr and Cys C content were measured by automatic biochemical analyzer. The expressions of 78 kDa glucose-regulated protein (GRP78), protein kinase RNA-like endoplasmic reticulum kinase (PERK), and activating transcription factor 4 (ATF4) and C/EBP-homologous protein (CHOP) were analyzed by Western blot. RESULTS: Resveratrol treatment significantly reduced the fasting blood glucose level, urinary protein level and renal pathological damage. The phosphorylation of PERK in the kidney of rats with diabetes was up-regulated, while resveratrol treatment reduced this change. The expression of p- PERK, GRP78, ATF4, and CHOP was significantly increased in rats with diabetes, while resveratrol treatment can reduce the increased level of those endoplasmic reticulum stress related factors. CONCLUSIONS: Resveratrol has a good therapeutic effect on DN in rats without side effect. The mechanism may be related to the regulation of endoplasmic reticulum stress response.
机译:目的:糖尿病肾病(DN)可引起慢性肾功能不全,并显着降低糖尿病患者的生活质量,并可能最终导致死亡。该研究探讨了内质网应激相关因子的表达,这些因子在DN的发展中具有重要作用,并探讨白藜芦醇对DN的影响及其可能的机制。材料与方法:将无特定病原体(SPF)级的健康雄性Sprague Dawley(SD)大鼠分为不同的组,以进行不同的治疗。通过腹膜内注射低剂量链脲佐菌素(STZ)(40 mg / kg)建立糖尿病大鼠模型。将正常大鼠和糖尿病模型大鼠分为四组,分别为正常对照组(N),正常对照组+白藜芦醇(N + R),模型组(M)和模型+白藜芦醇组(M + R),以进行不同的治疗。免疫组织化学观察肾脏组织学变化。采用葡萄糖氧化酶/过氧化物酶法测定FPG,用二辛可宁酸(BCA)法测定UP 24 h含量,用自动生化分析仪测定BUN,Scr和Cys C含量。 Western blot检测78kDa葡萄糖调节蛋白(GRP78),蛋白激酶RNA样内质网激酶(PERK),活化转录因子4(ATF4)和C / EBP同源蛋白(CHOP)的表达。结果:白藜芦醇治疗可显着降低空腹血糖水平,尿蛋白水平和肾脏病理损害。糖尿病大鼠肾脏中PERK的磷酸化被上调,而白藜芦醇治疗可减少这种变化。糖尿病大鼠中p-PERK,GRP78,ATF4和CHOP的表达显着增加,而白藜芦醇治疗可以减少那些内质网应激相关因子的升高。结论:白藜芦醇对大鼠DN有良好的治疗作用,且无副作用。该机制可能与内质网应激反应的调节有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号